Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Inotrem's investors include Bpifrance, Andera Partners, Sofinnova Partners, Invus, BioMedPartners.
Inotrem is headquartered in Paris, France.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Inotrem is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inotrem — Funding & Investors." VCBacked, November 6, 2023, https://www.vcbacked.co/company/inotrem. Accessed September 13, 2026.
VCBacked. (2023). Inotrem — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/inotrem
{{cite web |title=Inotrem — Funding & Investors |url=https://www.vcbacked.co/company/inotrem |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated